Biochemistry, Genetics and Molecular Biology
Genomics
100%
Gene Expression
100%
Overall Survival
100%
Transcriptomics
100%
Gene Signature
100%
Clinical Trial
100%
Histone Deacetylase
100%
Doxorubicin
100%
Gene Expression Profiling
100%
extracellular signal regulated kinase
100%
Event Free Survival
100%
Retrospective Study
100%
Metastasis Free Survival
100%
Keyphrases
Molecular Characterization
100%
Triple-negative Breast Cancer
100%
Pathological Response
100%
Neoadjuvant Therapy
100%
Pathological Outcomes
100%
Prospective Evaluation
100%
Metaplastic Breast Carcinoma
100%
Pathological Complete Response
66%
Tumor
33%
Complete Response Rate
33%
Gene Signature
33%
Survival Outcomes
33%
Clinical Outcomes
16%
Statistical Significance
16%
Mitogen-activated Protein Kinase
16%
Overall Survival
16%
Doxorubicin
16%
Breast Cancer Subtypes
16%
Molecular Profiling
16%
Histone Deacetylase 1 (HDAC1)
16%
Gene Expression Profile
16%
Prospective Clinical Trial
16%
Transcriptome Profile
16%
Clinical Correlation
16%
Triple Negative
16%
Path Analysis
16%
Event-free Survival
16%
Rare Subtype
16%
Genetic Profile
16%
Vulnerability
16%
Metastasis-free Survival
16%
PI3KCA
16%
Response to Neoadjuvant Therapy
16%
Medicine and Dentistry
Breast Cancer
100%
Triple Negative Breast Cancer
100%
Neoadjuvant Therapy
100%
Neoplasm
28%
Gene Expression Profiling
14%
Retrospective Study
14%
Gene Expression
14%
Clinical Trial
14%
Overall Survival
14%
Molecular Profiling
14%
Doxorubicin
14%
extracellular signal regulated kinase
14%
Event Free Survival
14%
Transcriptomics
14%
Histone Deacetylase
14%
Metastasis Free Survival
14%